Education

1989 M.D. and research degree in Molecular Endocrinology (Summa cum Laude), Federico II University, Naples, Italy

Positions

1984-1989. Internship, Molecular Endocrinology Program, Federico II University, Naples, Italy

1990-1992 Postdoctoral fellow, European Molecular Biology Laboratory. Heidelberg, Germany

1992-1996 Scientist and Scientific Cofounder. Mitotix Inc. Cambridge, MA

1996-1999 Assistant Professor, Department of Pathology, New York University School of Medicine. NYC, NY

1999-2005 Associate Professor (Tenured 2003), Department of Pathology and NYU Cancer Institute, NYU School of Medicine

2001-2008 Leader of the Growth Control Program at the NYU Cancer Institute

2005-present May Ellen and Gerald Jay Ritter Professor of Oncology, Department of Pathology and NYU Cancer Institute, NYU School of Medicine

2008-present Deputy Director, NYU Cancer Institute

2008-present Investigator, Howard Hughes Medical Institute

Awards and Honors

1987-1990 AIRC (Italian Association for Cancer Research) Fellow

1988 MPI (Italian Ministry of Education) Summer Scholar

1989 Summa cum Laude, M.D.

1990-1991 CEC (Commission of European Communities, Brussels, Belgium) Fellow

1991-1992 AIRC (Italian Association for Cancer Research) Fellow

1992 EMBL (European Molecular Biology Laboratory) Fellow

1993-1996 Human Frontiers Science Program Organization award

2000-2004 Irma T. Hirschl Scholar

2006 NIH (National Institutes of Health) Merit Award

2007 Multiple Myeloma Research Foundation Senior Award

2007 The Interurban Clinical Club lecture, Albert Einstein College of Medicine, NY

2007 The Eunice and Irving Leopold lecture, University of Pennsylvania, PA

Advisory Boards and Consultancy

1996-1997 European Institute of Oncology, Milan, Italy

1997-present Invitrogen, Carlsbad, CA

1998-2000 Millenium Inc., Cambridge, MA

2000-2004 Celgene Corp., San Diego, CA

2005 Johnson & Johnson Pharmaceutical, Raritan, NJ

2005-2006 Merck Research Laboratories, Boston, MA

2008-present American Italian Foundation Scientific Advisory Board, New York, NY

2008-present Intermediary Technology Institute, Scientific Advisory Board, Dundee, Scotland

Major Administrative Responsibilities

2001-2003 Co-Leader (together with E. Skolnik) of the Growth Control Program at the NYU Cancer Institute

2003-2008 Leader of the Growth Control Program at the NYU Cancer Institute

2008-present Deputy Director, NYU Cancer Institute

Editorial Positions

2000-present Faculty of 1000 (Cell Growth and Division section)

2003-2006 Cell Cycle

2003-present Cancer Research

2004-present Current Cancer Therapy Reviews

2004-present Bio Med Central Cell Biology

2005-present Cell Division, a journal of the Bio Med Central family (Founder editor and editor-in-chief)

2006-present Ubiquitin-proteasome system, a journal of the Bio Med Central family

2007-2012 Journal of Biological Chemistry